Real-world evidence generation, healthcare economics, reimbursement strategy, value evidence, and decision support for pharma, MedTech, and life sciences teams.
Practice leads assemble specialized teams based on project requirements, with methods, assumptions, and deliverables documented for internal review.
The practice supports teams that need credible evidence, healthcare economics, and reimbursement reasoning for product strategy, market access, regulatory questions, and internal decision-making.
Engagements are scope-based and designed around the decision, evidence need, data environment, timeline, and review context.
Healthcare work often combines evidence generation, healthcare economics, access strategy, and applied methods.
Real-world evidence strategy, data source evaluation, harmonization, governance, and analysis-ready evidence pipelines.
Cost-effectiveness, budget impact, reimbursement logic, decision-analytic models, validation, and documentation.
External control arms, target trial emulation, protocol logic, eligibility design, sensitivity analysis, and documentation.
Evidence strategy for reimbursement, payer discussions, formulary positioning, value demonstration, and product planning.
Clinical comparisons and healthcare economics analyses using fit-for-purpose causal methods, confounding control, and sensitivity analysis.
AI-enabled evidence generation, clinical NLP, LLM-assisted analytics, multimodal health data, and translational programs.
Senior support for evidence, access, and strategy decisions.
A defined RWE, HEOR, external control, reimbursement, or dossier-support engagement.
Short work supporting a specific access, commercial, regulatory, or evidence decision.
Engagement structure and pricing are discussed directly based on scope.
Discuss healthcare work →